BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9599697)

  • 1. Dermal toxicity: alternative methods for risk assessment.
    Goldberg AM; Maibach HI
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):493-6. PubMed ID: 9599697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: "Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals".
    Ulmer WR
    Int J Toxicol; 2003; 22(6):475-6; author response 476-8. PubMed ID: 14680995
    [No Abstract]   [Full Text] [Related]  

  • 3. [Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals].
    Chomiczewska D; Kieć-Swierczyńska M; Krecisz B
    Med Pr; 2009; 60(3):209-14. PubMed ID: 19746889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro alternatives for ocular irritation.
    Curren RD; Harbell JW
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):485-92. PubMed ID: 9599696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative methods for the replacement of eye irritation testing.
    Lotz C; Schmid FF; Rossi A; Kurdyn S; Kampik D; De Wever B; Walles H; Groeber FK
    ALTEX; 2016; 33(1):55-67. PubMed ID: 26626125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens.
    Corsini E; Mitjans M; Galbiati V; Lucchi L; Galli CL; Marinovich M
    Toxicol In Vitro; 2009 Aug; 23(5):789-96. PubMed ID: 19397996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal cytokines in murine cutaneous irritant responses.
    Effendy I; Löffler H; Maibach HI
    J Appl Toxicol; 2000; 20(4):335-41. PubMed ID: 10942909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the skin sensitization in vitro data assessment paradigm in 2009--a chemistry and QSAR perspective.
    Roberts DW; Patlewicz GY
    J Appl Toxicol; 2010 Apr; 30(3):286-8; discussion 289. PubMed ID: 20131408
    [No Abstract]   [Full Text] [Related]  

  • 9. Three dimensional in vitro human tissue models for ADME-Tox studies.
    Chun YJ
    Drug Metab Pharmacokinet; 2014; 29(6):431-432. PubMed ID: 25742743
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals.
    Stobbe JL; Drake KD; Maier KJ
    Int J Toxicol; 2003; 22(2):99-107. PubMed ID: 12745991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new 3D reconstituted human corneal epithelium model as an alternative method for the eye irritation test.
    Jung KM; Lee SH; Ryu YH; Jang WH; Jung HS; Han JH; Seok SH; Park JH; Son Y; Park YH; Lim KM
    Toxicol In Vitro; 2011 Feb; 25(1):403-10. PubMed ID: 21040779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECVAM and new technologies for toxicity testing.
    Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
    Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Read-across to rank skin sensitization potential: subcategories for the Michael acceptor domain.
    Schultz TW; Rogers K; Aptula AO
    Contact Dermatitis; 2009 Jan; 60(1):21-31. PubMed ID: 19125718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CON4EI: CONsortium for in vitro Eye Irritation testing strategy.
    Van Rompay AR; Verstraelen S; Blaauboer BJ
    Toxicol In Vitro; 2018 Jun; 49():1. PubMed ID: 29685209
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of SV40 T-transformed human corneal epithelial cells to evaluate potential irritant chemicals for in vitro alternative eye toxicity.
    Kim CW; Park GT; Bae ON; Noh M; Choi KC
    J Pharmacol Toxicol Methods; 2016; 80():82-9. PubMed ID: 27233534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction, refinement and replacement: putting the immune system to work.
    Kimber I
    Altern Lab Anim; 2002; 30(6):569-77. PubMed ID: 12511192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of in vitro data into local irritation/corrosion testing strategies by means of SAR considerations: assessment of chemicals.
    Gerner I; Schlede E
    Toxicol Lett; 2002 Feb; 127(1-3):169-75. PubMed ID: 12052655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition.
    Debbasch C; Ebenhahn C; Dami N; Pericoi M; Van den Berghe C; Cottin M; Nohynek GJ
    Food Chem Toxicol; 2005 Jan; 43(1):155-65. PubMed ID: 15582208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem repeated irritation test (TRIT) studies and clinical relevance: Post 2006.
    Reddy R; Maibach H
    Cutan Ocul Toxicol; 2019 Dec; 38(4):309-314. PubMed ID: 29886752
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative in vitro to in vivo extrapolation (QIVIVE): An essential element for in vitro-based risk assessment.
    Yoon M; Blaauboer BJ; Clewell HJ
    Toxicology; 2015 Jun; 332():1-3. PubMed ID: 25680635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.